Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04605848
Other study ID # UAPV_180620_AVJ
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date July 3, 2020
Est. completion date October 20, 2023

Study information

Verified date May 2024
Source University of Avignon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients affected by pheochromocytoma (PHEO) have brown-adipose tissue (BAT) hyperactivation. They perform, in routine settings, a FDG PET-CT scan. The high metabolic activity of BAT and its ability to consume both glucose and fatty acid suggest that it may have potential as a therapeutic target in the treatment of obesity. However, alternative non-invasive techniques to PET-CT BAT detection still need more validation. Accordingly, our aim will be to measure the temperature and microcirculation of the skin overlaying BAT depots in the region of FDG-uptake detected by 18F-FDG PET/CT before and after a cold test in PHEO patients.


Description:

Objectives and Methodology: - To analyse the change in temperature and microcirculation of the skin overlaying BAT depots in the region of FDG-uptake detected by 18F-FDG PET/CT before and after a cold test in PHEO patients. - To check the decreased temperature and microcirculatory response after a cold test following resection of the tumor All the patients affected by will benefit from a: - clinical: treatments - biological evaluations: glycemia, triglycerides, total cholesterol, HDL-C, LDL-C, plasma epinephrine and norepinephrine, urine catecholamine - cutaneous microcirculation by means of Laser Speckle Imaging will be recorded at rest and during a cold test in the supra-clavicular region - cutaneous microcirculation by means of Laser Doppler Flowmetry will be recorded at rest and during a cold test with one probe in the supra-clavicular region and one probe in umbilical region - skin temperature by means of infrared thermography will be recorded at rest and during a cold test in the supra-clavicular region Patients who will have surgery will be investigated before and after one year following resection of the tumor.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date October 20, 2023
Est. primary completion date April 29, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Patients with confirmed pheochromocytoma and/or paraganglioma Exclusion Criteria: - pregnant woman - breastfeeding woman

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Infrared themrography
measurement of temperature and microcirculation of the skin overlaying BAT depots in the region of FDG-uptake detected by 18F-FDG PET/CT before and after a cold test

Locations

Country Name City State
France Pôle ENDO- Hopital la Conception APHM Marseille Paca

Sponsors (3)

Lead Sponsor Collaborator
University of Avignon Assistance Publique Hopitaux De Marseille, Centre Hospitalier Henri Duffaut - Avignon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Skin temperature in supra-clavicular region in basal condition (TSCRbasal) Skin temperature in supra-clavicular region will be recorded by infrared thermography (FLIR camera) in basal condition Day 0
Primary Skin temperature in supra-clavicular region during a cold test (TSCRcold) Skin temperature in supra-clavicular region will be recorded by infrared thermography (FLIR camera) during a cold test (feet in water at 19°C during 20min) Day 0
Primary Baseline difference in skin temperature in supra-clavicular region (diff TSCR) diff TSCR (day 0) = TSCRcold - TSCRbasal Day 0
Secondary Cutaneous blood flow in supra-clavicular region in basal condition (PUbasal) Cutaneous blood flow in supra-clavicular region will be recorded by Laser Speckle Imaging (PeriCam) in basal condition Day 0
Secondary Cutaneous blood flow in supra-clavicular region during a cold test (PUcold) Cutaneous blood flow in supra-clavicular region will be recorded by Laser Speckle Imaging (PeriCam) during a cold test (feet in water at 19°C during 20min) Day 0
Secondary Baseline difference in cutaneous blood flow in supra-clavicular region (?PU) diff PU (day0) =PUcold-PUbasal Day 0
Secondary Volume of Brown Adipose Tissue detected by PET-CT 18FDG PET-CT will be performed and volume will be segmented by PET/CT Viewer.. Day 0
Secondary Activity of Brown Adipose Tissue detected by PET-CT 18FDG PET-CT will be performed and BAT activity (Standardized Uptake Value (SUV) will be segmented by PET/CT Viewer.. Day 0
Secondary Change from baseline difference in skin temperature in supra-clavicular region ( ? diffTSCR) at 12 months ? diff TSCR = diff TSCR(month12) - diff TSCR (day0) Month 12
Secondary Change from baseline difference in cutaneous blood flow in supra-clavicular region ( ? diff PU) at 12 months ? diff PU = diff PU (month12) - diff PU (day0) Month 12
Secondary Volume of Brown Adipose Tissue detected by PET-CT 18FDG PET-CT will be performed and volume will be segmented by PET/CT Viewer.. Month 12
Secondary Activity of Brown Adipose Tissue detected by PET-CT 18FDG PET-CT will be performed and BAT activity (Standardized Uptake Value (SUV) will be segmented by PET/CT Viewer.. Month 12
See also
  Status Clinical Trial Phase
Recruiting NCT06050057 - Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
Recruiting NCT05636618 - Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors Phase 1/Phase 2
Terminated NCT03986593 - Cryoablation of Bone Metastases From Endocrine Tumors N/A
Terminated NCT05948137 - F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma
Completed NCT00970970 - Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease
Active, not recruiting NCT00436735 - Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors Phase 1
Recruiting NCT00669266 - Adrenal Tumors - Pathogenesis and Therapy
Recruiting NCT05069220 - 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor Early Phase 1
Recruiting NCT06062082 - Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma
Recruiting NCT04573816 - Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma
Active, not recruiting NCT04400474 - Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study Phase 2
Not yet recruiting NCT06045260 - "Receptor Radionuclide Therapy With 177Lu-DOTATOC Phase 2
Completed NCT00001147 - Blood Sampling for Neurochemical and Genetic Testing N/A
Terminated NCT00002947 - Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer Phase 1
Completed NCT00001229 - Diagnosis and Treatment of Pheochromocytoma N/A
Completed NCT01967576 - Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma Phase 2
Recruiting NCT03160274 - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Recruiting NCT03206060 - Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma Phase 2
Not yet recruiting NCT04788927 - Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study
Enrolling by invitation NCT03474237 - A Prospective Cohort Study for Patients With Adrenal Diseases